The MPL gene codes for the thrombopoietin receptor, whose ligand specifically controls megakaryocytic differentiation. To understand the molecular basis for the megakaryocytespecific expression of MPL, we analyzed the promoter of this gene. A 200 bp fragment is sufficient for high-level specific expression. This fragment can bind several trans-acting factors in vitro, including GATA-1 and members of the Ets family. GATA-1 binds with low affinity to a unique GATA motif at -70 in the MPL promoter, and destruction of this site yields only a modest decrease in expression level in HEL cells. Ets proteins also bind with low affinity to two sites. One is located at position -15 and its destruction reduces HE MPL GENE is the cellular homologue of the murine T v-mpl oncogene. This oncogene was found in the genome of the murine myeloproliferative leukemia virus, which induces a broad spectrum of myeloid leukemia in mice.' MPL encodes a member of the hematopoietic receptor superfamily and recently, a number of reports have demonstrated that this protein plays an essential role in megakaryocytic differentiation. First, antisense oligonucleotides specific for the MPL mRNA can specifically inhibit megakaryocytic colony formation in culture.' Second, the ligand for MPL was cloned by several groups and it was shown to be identical to thrombopoietin (Tpo), a megakaryopoietic activity that had been detected in aplastic Third, MPL-deficient mice generated by gene targeting have a specific 85% decrease in their number of platelets and megakaryocytes and increased concentrations of circulating Tpo, but no other hematopoietic abnormality.8 MPL transcripts can be detected in a fraction of CD34-positive hematopoietic progenitors, in megakaryocytes and platelets, and also in continuous cell lines expressing megakaryocytic markers, such as HEL and DAMI.' Thus, it represents an early marker of megakaryocytic differentiation.
indispensable only for erythropoiesis in vivo."." Our previous work has shown that the promoter of the human glycoprotein IIb (GpIIb) gene, whose expression is restricted to megakaryocytes, contains a tandem of binding sites for GATA-1 and for members of the Ets family of transcriptional activators.I4 This association of motifs can be found in most megakaryocytic regulatory region^.'^ Mutagenesis of either the GATA or the Ets motif in the GpIIb promoter only results in a 50% decrease of expression in transient transfection assays, suggesting that the proteins bound to these sequences do not act ~ynergistically.'~ This is in sharp contrast to the synergy observed between GATA-1 and proteins bound on adjacent Sp 1/CACC motifs in erythroid-specific regulatory regions. 16 To date, no particular Ets protein has been implicated in the regulation of megakaryocytic genes. The Ets family contains approximately 30 members described in various animal species, and several of these factors regulate lineagespecific genes in the hematopoietic system. For instance, PU.l controls the expression of the myeloid CDllb prom o d 7 and the macrophage colony-stimulating factor (M-CSF) gene"; in T cells, Ets-1 may be involved in the expression of lineage-specific genes, whereas Elf-1 may control another subset of genes during activation."
To study the mechanisms of gene activation in megakaryocytes, we have previously cloned the human MPL gene and determined its structure." Here, we show that a 200 bp promoter fragment displays cell-type-specific activity in transient transfection assays. Analysis of protein-DNA interactions on this fragment reveals two Ets binding sites and one GATA binding site. Transactivation assays and sitedirected mutagenesis experiments show that all three motifs are involved in expression of the MPL promoter.
MATERIALS AND METHODS
Plasmids. The -700 promoter is an Acc I-EstE I1 fragment?' the -200 promoter a Stu I-EstE I1 fragment and the -4200 promoter a EcoR V-EstE I1 fragment. These were cloned at the Egl I1 site in P B L -C A T~.~' The two putative initiator ATG codons from MPL are then placed in-frame with the CAT coding sequence. The -37 GPB construct was described previously?2
These were carried out as described." Each transfection was performed at least three times.
Nuclear extracts were prepared ac- cording to a modification of Dignam's method.',23 Probes for footprint assays were made by the polymerase chain reaction (PCR), one of the oligonucleotides being "P-labeled. DNase I footprints and gel retardation experiments were performed as de~cribed.'~ Extracts of recombinant baculovirus-infected insect cells were made as described p r e v i~u s l y . '~~'~~~~ This was performed with the Sculptor in vitro mutagenesis kit (Amersham, Little Chalfont, Bucks, UK). Each mutated promoter fragment was sequenced entirely and subcloned in pBL-CAT3 as a Stu I-BstE I1 fragment.
Site-directed mutagenesis.
RESULTS
A 200-bp promoter fragment displays megakaryocytic specificity. We analyzed the cell-type specificity of the MPL promoter by transient transfection assays. Three constructs were made, in which the chloramphenicol acetyl transferase (CAT) reporter gene was driven by promoter fragments extending to -4200, -700, and -200 relative to the transcriptional start. These constructs were introduced into HeLa (nonhematopoietic), K562 (erythroid), Jurkat (T lymphoid), and HEL (erythro-megakaryocytic) cells by electroporation together with a plasmid expressing the firefly luciferase gene to correct for transfection efficiency. 22 We have previously shown that transcription of the -700 construct is correctly initiated in these assays.20 Figure 1 shows that all three constructs yielded strong CAT activities in HEL cells, which express the endogenous MPL gene, but were totally inactive in K562, Jurkat, and HeLa cells, like the endogenous MPL gene.
The absence of activity of the MPL promoter in K562 cells contradicted our previous report, in which the -700 fragment was active in these same cells." Subsequent cell surface marker analysis performed by Dr William Vainchenker (Institut Gustave Roussy, Villejuif, France) showed that our previous batch of K562 cells had been contaminated with HEL cells (not shown). K562 cells obtained from the American Type Culture Collection (ATCC), as well as from Dr Vainchenker's laboratory, were reproducibly unable to express the MPL-CAT constructs. Therefore, we conclude that the -200 promoter fragment is able to confer cell-type specific activity to a reporter gene in transient transfection assays.
DNase I footprinting on the -200 promoter fragment. DNA sequence analysis of the -200 promoter fragment reveals several potential binding sites for proteins of the GATA and Ets families: a GATA motif is found at -75 and two Ets motifs at -65 and -25.*' In addition, a GGGCAGG sequence at -100 and a GGGCTGG sequence at -50 may constitute Spl-binding sites. In order to determine whether these were actual protein binding sites, we performed in vitro DNase I footprint assays on the -200 promoter fragment. Two "sense" oligonucleotides located at -300 and -100 and two "antisense" oligonucleotides located at -70 and +loo, were used to make probes by the polymerase chain Six regions are protected from DNase I digestion in the presence of nuclear extracts. Footprints centered on nucleotides -175 (Fl), -140 (F2), -105 (F3), and -15 (F5) can be detected with HeLa, K562, and HEL extracts. The region around -70 displays partial protection in all extracts (F4), which corresponds to the Ets and Spl motifs, but a weak footprint over the GATA site in HEL and K562 extracts is revealed by characteristic DNase I cutting sites on each side (-82 and -72). Finally, a region between +15 and +55 is covered in HEL extracts, whereas the HeLa and K562 extracts protect only the +15 to +38 region (F6). In some experiments, the +60 to +80 region was also protected by HEL nuclear extracts (bottom of Fig 2C and top of Fig 2A) . These footprints are summarized on the sequence of the promoter in Fig 2D. Identification of nuclear factors by gel retardation assays. Double-stranded oligonucleotides corresponding to individual footprints were then used to characterize DNA-protein interactions in gel retardation assays. The sequence of these oligonucleotides is indicated in Fig 2D. Competition with a 1 00-fold excess of cold oligonucleotide was performed to test the specificity of the retarded complexes (Fig 3A) . Competition with oligonucleotides bearing already characterized binding sites allowed us to identify a number of binding activities.
First, four regions were able to bind proteins of the Spl family, as judged by competition with a known Spl oligonucleotide and by the reverse experiment. These are the -175/ Fl, -1OO/F3, -7O/F4, and -15/F5 regions (Fig 3A, complexes marked by 0, and data not shown). A competition experiment using the -7O/F4 oligo is shown in Fig 3B. These results are coherent with the presence of G-C-rich sequences in these regions (Fig 2D) . In addition, the -15/ F5 region is recognized by another species (Fig 3A, complex  0 For
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HEL extracts. Cross-competition experiments between the -140F2 and +30/F6 oligos demonstrated that the proteins that bind these regions are related (Fig 3B and data not  shown) , and that the -140 region displays higher affinity than +30 for these proteins (not shown).
Finally, one non-tissue-specific complex appeared specifically with the +30F6 oligonucleotide (Fig 3A, band a ) . This complex was only partially competed by a 100-fold excess of the +30 oligonucleotide itself, indicating that this factor binds with a relatively low affinity.
As expected, the -7O/F4 oligo is recognized by GATA-1 in K562 and HEL extracts (Fig 3, A and B, complex +) . A retarded complex containing both GATA-1 and Spl can also be seen with these extracts (@+). Cross-competition with various amounts of a strong GATA-1 binding site located at -70 in the porphobilinogen deaminase promote?7 showed that the TCAGATACA motif in the MPL promoter binds GATA-1 with low affinity (data not shown). This is coherent with the under-representation of T at -3, C at +5, and A at +6 (G in GATA = + 1) in the random site selection experiments performed by Merika and Orkin with GATA-1 or GATA-2.28
No complex corresponding to Ets proteins could be seen in our gel retardation experiments with the -70/F4 and -15/ F5 regions. To test the ability of the Ets motifs located at positions -65 and -25 to bind Ets proteins, we performed gel retardation experiments with specific Ets proteins. Baculovirus vectors expressing Ets-1, Fli-1, or Elf-1 were used to infect insect cells and total protein extracts were made. Figure 3C shows the result of an experiment using Fli-lproducing cells. While the Ets motif located at -35 in the GpIIb promoter is a strong binding site for Fli-1, the -15 region of the MPL promoter showed a moderate affinity, and the -70 region a very low affinity, for Fli-1. The -175 and -140 regions, as well as a mutant GpIIb Ets binding site, were inefficient competitors. Identical results were obtained with Ets-1 and Elf-1 (not shown). Therefore, the apparent lack of binding of Ets proteins in our crude nuclear extracts might be explained by the low affinity of these sites.
Trans-activation of the -200 MPL promoter by GATA-I, Ets-1, and Fli-I. The MPL promoter contains GATA and Ets binding sites, including a GATA-Ets tandem at -70. This appears to be a common feature of megakaryocytic regulatory but the functional relevance of these tandems has only been established in the case of the GpIIb p r~m o t e r '~'~~ and the GpIIb enhan~er.".~'
To study the functional role of these motifs in the MPL promoter, we performed trans-activation assays. HeLa cells were co-transfected with the -200 MPL-CAT reporter construct and expression vectors encoding either GATA-1, Ets-1, or Fli-1. Figure 4 shows that GATA-1, Ets-1, and Fli-1 are indeed able to stimulate CAT activity from the reporter construct (3-, 7-and 6-fold, respectively) and that the effects of GATA-1 and Ets-1, or GATA-1 and Fli-1, are additive.
Site-directed mutagenesis identijies a crucial Ets motif in the MPL promoter. To study the relative contribution of the GATA motif and the two Ets motifs to the level of expression of the -200 MPL promoter in HEL cells, we performed site-directed mutagenesis on these sites. A point mutation destroying the GATA sequence (GATA-GCTA) led to complete loss of GATA-1 binding in vitro (not shown) and resulted in a 15% decrease of MPL promoter activity (Fig 5) . Similarly, we destroyed the Ets binding sites by changing the AGGAA sequence to ACCAA,35 which resulted in an 85% decrease in promoter activity when the -65 site was hit and a 50% decrease when the -25 site was mutated. Therefore, the Ets motifs, especially the -65 motif, appeared to be more important for MPL promoter function than the GATA site. In the GpIIb promoter, mutation of either the GATA or the Ets motif yielded a 60% decrease in activity.14 We conclude that, although the -65 Ets binding site has low affinity for Ets-1, Fli-1, or Elf-1, it is a major determinant of MPL promoter activity.
DISCUSSION
There is evidence for the existence of a bipotent erythroidmegakaryocytic progenitor in hematop~iesis.~~ In particular, GATA-1 was found to be expressed in both eythroid and megakaryocytic cells.'0,'' The functional study of a large number of erythroid regulatory regions has clearly established that all contain adjacent binding sites for GATA-1 and proteins of the Spl/Kriippel/EKLF family. Furthermore, it was recently shown that GATA-1 is indeed able to synergize with Spl and also with Erythroid Kriippel-Like Factor (EKLF) to activate erythroid-specific transcription. l 6 Mouse embryos lacking the GATA-1 protein are defective for primitive and definitive erythrop~iesis,'~~" but their megakaryopoiesis does not seem to be affected. However, it cannot be excluded that GATA-2 may replace GATA-1 during megakaryopoiesis, as an increased expression of the former is detected during in vitro differentiation of GATA-1 -deficient ES cells.'* We have previously shown that the promoter of the human GpIIb gene contains adjacent GATA and Ets motifs that are equally important for its activity.I4 The GpIIb gene also contains an upstream enhancer region that contains additional GATA and Ets motif^.^' This organization is conserved in the rat GpIIb gene, and a recent study has shown that both proximal and distal GATA and Ets motifs contribute to its level of expression in primary rat megakaryocytes." However, the GpIIb gene was the only megakaryocyte-specific gene in which the regulatory role of tandem GATA and Ets binding sites had been shown. To understand the basis for the observed co-expression of GpIIb and the thrombopoietin receptor (MPL),39 we characterized the MPL promoter by deletion and mutation analysis, trans-activation experiments and in vitro DNA-protein interactions. We show that the MPL promoter can be bound by GATA-1 and Ets proteins, including Ets-1, Fli-1, and Elf-1, and that the Ets motif adjacent to the GATA site is crucial for its expression. These results suggest that the presence of closely spaced GATA and Ets binding sites is indeed a hallmark of megakaryocytic regulatory regions.
Our results show that the binding of Ets proteins is more important than that of GATA-1 for efficient expression of the MPL promoter (in transient transfection experiments) and that GATA-1 and Ets-1 (or Fli-I) do not act synergisti- The double symbol IO+) points t o a retarded complex that contains both GATA-1 and Spl. Binding of nuclear proteins t o the +30/F6 oligo in HeLa or HEL extracts was challenged by a 100-fold excess of either the Gpllb Ets binding site or the -140/F2 oligo. IC) Gel retardation assay using the Ets motif from the human Gpllb promoter as a probe. A 25-or 100-fold excess of various oligonucleotides was added for competition: the Gpllb Ets oligo itself, a mutant Gpllb Ets oligo, -175/F1, -7O/F4, -15/F5 and -140/F2. These fragments were incubated with an insect cell extract containing the recombinant Fli-1 protein.
For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From cally on this promoter. This constitutes an essential difference between megakaryocytic and erythrocytic promoters. At the moment, PU.l/Spi-l is the only member of the Ets family whose role in hematopoiesis has been successfully examined by gene targeting experiments. Embryos lacking the PU.1 protein have a severe defect in hematopoiesis that could be due to an alteration of the stem cell compartment.'" However, PU.1 is unlikely to be directly involved in megakaryopoiesis, as it is weakly expressed in megakaryocytic cell lines, and as it cannot transactivate the Gpllb promoter (our unpublished results). Furthermore, Ets motifs found in megakaryocytic genes cannot bind PU. 1 directly. Knock-out experiments on many Ets genes should be complicated by the spatial and functional redundancy between these proteins and it is expected that, in many cases, no phenotype will be observed. In HEL cells for instance, mRNAs for Ets-I, Ets-2, Fli-1. Elf-1, SAP-I , and PU. 1 can be detected (our unpublished results). The ERM mRNA is also expressed in these cells.' ' An alternative way to study the role of Ets proteins in megakaryopoiesis would be to target the expression of a dominant-negative Ets protein to the megakaryocytes of transgenic mice. We are currently exploring this possibility. For personal use only. on September 14, 2017. by guest www.bloodjournal.org From It should be noted that patients bearing a deletion of chromosome region 1 lq23-1 lqter suffer from thrombocyto~e n i a .~' This region contains two Ets genes, Ets-1 and Fli-I, whose products are able to bind and trans-activate both the GpIIb and the MPL promoters. In addition, the expression of Ets-1 and mi-1 mRNAs, but not that of Ets-2 or PU.l, increases with phorbol ester treatment of HEL cells, in parallel with the expression of GpIIb (our unpublished results). It is therefore possible that Ets-1 and Fli-1 are directly involved in megakaryocyte-specific gene expression.
Finally, it has been shown recently that inactivation of the p45 NF-E2 gene in mice results in severe thr~mbopenia.~~
In these mutant mice, polyploid megakaryocytes are present, they express specific markers such as GpIIb and PF4 and their response to thrombopoietin is normal, but they do not produce platelets. As no NF-E2 binding site can be detected in the regulatory regions we have studied, the action of NF-E2 in the megakaryocytic lineage is probably exerted later than the onset of expression of markers such as MPL or GpIIb. Therefore, different genetic mechanisms are likely to apply to commitment to the megakaryocytic lineage and to platelet formation and release.
NOTE ADDED IN PROOF
After this paper was submitted, it was shown by Hashimoto and Ware that GATA and Ets binding sites are crucial for expression of the glycoprotein Ibcv promoter ( J B i d Chem 270:24532, 1995).
